Standout Papers
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck (2006)
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival (2009)
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 (2014)
Immediate Impact
6 by Nobel laureates 4 from Science/Nature 87 standout
Citing Papers
Head and neck cancer
2021 Standout
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Works of James A. Bonner being referenced
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer
2001
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| James A. Bonner | 6490 | 6482 | 4680 | 230 | 13.8k | |
| Merrill S. Kies | 5225 | 7226 | 5611 | 177 | 14.3k | |
| David Raben | 5462 | 6676 | 5071 | 234 | 14.9k | |
| J. Giralt | 4481 | 5208 | 5602 | 116 | 11.4k | |
| Paul M. Harari | 7072 | 8412 | 5795 | 300 | 17.7k | |
| K. Kian Ang | 4403 | 4102 | 5241 | 176 | 11.4k | |
| Bonnie S. Glisson | 4525 | 7543 | 5768 | 273 | 14.4k | |
| Nancy Y. Lee | 5436 | 5940 | 8793 | 369 | 18.1k | |
| Karen K. Fu | 4855 | 4681 | 7422 | 119 | 13.7k | |
| John A. Ridge | 4454 | 5590 | 9607 | 201 | 14.8k | |
| Theodore L. Phillips | 8037 | 4645 | 2490 | 309 | 16.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...